Occurrence of Dyskalemia With Treatment for Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1090 participants.

Also called NCT05155436

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,090 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05155436
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Bangladesh (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05155436. Allocation not applicable; no masking; primary purpose treatment. Start 2022-01-15 (actual); primary completion 2023-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Occurrence of Dyskalemia With Treatment for Hypertension
Acronym
OK
Condition
Hypertension
Condition
Potassium Imbalance
Intervention (Drug)
Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
Lead sponsor
National Heart Foundation of Bangladesh (class: other)
Collaborator
National Heart Foundation Hospital and Research Institute of Bangladesh (class: not stated)
Collaborator
Johns Hopkins University (class: other)
Collaborator
Resolve to Save Lives (class: other)

Record details

Record id
cardio:ct-nct05155436
Content hash
953ca7c8992960ba04893dc9d8ad2a7100ff4456b543b29a0495452039ba1fe7